$NGTF
NightFood Holdings, Inc.

2022 Q4 Form 10-Q Financial Statement

#000121390022074226 Filed on November 21, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $13.37K $79.97K $114.5K
YoY Change -83.16% -30.13% -9.87%
Cost Of Revenue $42.00K $125.1K $124.9K
YoY Change -52.33% 0.2% -45.64%
Gross Profit -$28.63K -$45.15K -$10.42K
YoY Change 227.57% 333.3% -89.86%
Gross Profit Margin -214.15% -56.46% -9.1%
Selling, General & Admin $104.3K $126.3K $823.3K
YoY Change -77.79% -84.65% 89.98%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $690.9K $638.6K $823.3K
YoY Change 47.11% -22.43% 89.99%
Operating Profit -$677.5K -$558.6K -$833.7K
YoY Change 41.63% -33.0% 55.53%
Interest Expense -$3.412M -$155.9K $0.00
YoY Change 1140.3% -100.0%
% of Operating Profit
Other Income/Expense, Net -$544.6K
YoY Change
Pretax Income -$4.560M -$1.201M -$833.7K
YoY Change 483.96% 44.07% -11.67%
Income Tax
% Of Pretax Income
Net Earnings -$4.560M -$1.201M -$833.7K
YoY Change 483.96% 44.07% -11.67%
Net Earnings / Revenue -34110.72% -1501.95% -728.42%
Basic Earnings Per Share -$0.08 -$0.01 -$0.01
Diluted Earnings Per Share -$0.08 -$0.01 -$10.12K
COMMON SHARES
Basic Shares Outstanding 96.46M shares 95.96M shares 82.39M shares
Diluted Shares Outstanding 97.44M shares 92.71M shares 82.39M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $49.01K $220.4K $471.7K
YoY Change -93.83% -53.27% 5542.46%
Cash & Equivalents $49.01K $220.4K $471.7K
Short-Term Investments
Other Short-Term Assets $103.0K $106.7K $37.49K
YoY Change -13.49% 184.73% -86.22%
Inventory $453.6K $433.2K $491.6K
Prepaid Expenses
Receivables $74.42K $130.4K $77.43K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $680.1K $890.7K $1.078M
YoY Change -51.41% -17.39% 92.94%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $680.1K $890.7K $1.078M
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $680.1K $890.7K $1.078M
YoY Change -51.41% -17.39% 92.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $515.0K $434.4K $353.7K
YoY Change 99.77% 22.83% -69.18%
Accrued Expenses $27.00K $9.000K $0.00
YoY Change -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $3.317M $894.8K $0.00
YoY Change 3998.07% -100.0%
Long-Term Debt Due $2.794M
YoY Change
Total Short-Term Liabilities $3.859M $1.342M $353.7K
YoY Change 1039.3% 279.5% -93.11%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.859M $1.342M $353.7K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $3.859M $1.342M $353.7K
YoY Change 1039.31% 279.5% -93.11%
SHAREHOLDERS EQUITY
Retained Earnings -$37.55M -$29.65M
YoY Change
Common Stock $99.81K $95.96K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.179M -$451.5K $724.5K
YoY Change
Total Liabilities & Shareholders Equity $680.1K $890.7K $1.078M
YoY Change -51.41% -17.39% 92.94%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$4.560M -$1.201M -$833.7K
YoY Change 483.96% 44.07% -11.67%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$323.6K -$414.6K -$878.4K
YoY Change -42.43% -52.8% 138.59%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 152.1K $354.1K 308.2K
YoY Change -82.8% 14.91% 72.28%
NET CHANGE
Cash From Operating Activities -323.6K -$414.6K -878.4K
Cash From Investing Activities
Cash From Financing Activities 152.1K $354.1K 308.2K
Net Change In Cash -171.4K -$60.47K $0.00
YoY Change -153.1%
FREE CASH FLOW
Cash From Operating Activities -$323.6K -$414.6K -$878.4K
Capital Expenditures $0.00
Free Cash Flow -$878.4K
YoY Change 138.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Interest Expense Other
InterestExpenseOther
usd
CY2022Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
344151 usd
CY2022Q3 dei Document Type
DocumentType
10-Q
CY2022Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q3 dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
CY2022Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q3 dei Entity File Number
EntityFileNumber
000-55406
CY2022Q3 dei Entity Registrant Name
EntityRegistrantName
NIGHTFOOD HOLDINGS, INC.
CY2022Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-3885019
CY2022Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
520 White Plains Road
CY2022Q3 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 500
CY2022Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Tarrytown
CY2022Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2022Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10591
CY2022Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q3 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
96464484 shares
CY2022Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
220412 usd
CY2022Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
280877 usd
CY2022Q3 ngtf Net Allowance
NetAllowance
0 usd
CY2022Q2 ngtf Net Allowance
NetAllowance
0 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
130397 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
93674 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
433188 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
331531 usd
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
106745 usd
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
137797 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
890742 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
843879 usd
CY2022Q3 us-gaap Assets
Assets
890742 usd
CY2022Q2 us-gaap Assets
Assets
843879 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
434446 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
234152 usd
CY2022Q3 us-gaap Accrued Rent Current
AccruedRentCurrent
9000 usd
CY2022Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
535895 usd
CY2022Q3 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
358905 usd
CY2022Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
4041 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1342287 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
578303 usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
1 usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
1 usd
CY2022Q3 ngtf Preferred Stock Value1
PreferredStockValue1
2 usd
CY2022Q2 ngtf Preferred Stock Value1
PreferredStockValue1
3 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
95964484 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
95964484 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
91814484 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
91814484 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
95964 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
91814 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
29100518 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
28275216 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29648030 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-28101458 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-451545 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
265576 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
890742 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
843879 usd
CY2022Q3 us-gaap Revenues
Revenues
79970 usd
CY2021Q3 us-gaap Revenues
Revenues
114453 usd
CY2022Q3 ngtf Cost Of Product Sold
CostOfProductSold
125121 usd
CY2021Q3 ngtf Cost Of Product Sold
CostOfProductSold
124874 usd
CY2022Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
37166 usd
CY2021Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
305016 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
126341 usd
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
275372 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
349949 usd
CY2021Q3 us-gaap Professional Fees
ProfessionalFees
242866 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
638577 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
948128 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-558607 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-833675 usd
CY2022Q3 us-gaap Interest Expense Other
InterestExpenseOther
22946 usd
CY2022Q3 us-gaap Financing Interest Expense
FinancingInterestExpense
132983 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
57971 usd
CY2022Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
544545 usd
CY2022Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
642503 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1201110 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-833675 usd
CY2022Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
345462 usd
CY2021Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
289935 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1546572 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1123610 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
92713941 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
82394547 shares
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
265576 usd
CY2022Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
20010 usd
CY2022Q3 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
290070 usd
CY2022Q3 ngtf Warrants Issued And Warrants Dilutive Adjustment As Financing Cost
WarrantsIssuedAndWarrantsDilutiveAdjustmentAsFinancingCost
65783 usd
CY2022Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
108126 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1201110 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-451545 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1110001 usd
CY2021Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
140000 usd
CY2021Q3 ngtf Issuance Of Common Stock From For Preferred Series B Conversion
IssuanceOfCommonStockFromForPreferredSeriesBConversion
0 usd
CY2021Q3 ngtf Issued From Private Placement
IssuedFromPrivatePlacement
335000 usd
CY2021Q3 ngtf Issued Financing Cost
IssuedFinancingCost
-26800 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-833675 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
724526 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1201110 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-833675 usd
CY2022Q3 ngtf Warrants Issued For Services
WarrantsIssuedForServices
108126 usd
CY2022Q3 ngtf Warrant Issued For Financing Cost
WarrantIssuedForFinancingCost
65783 usd
CY2022Q3 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
20010 usd
CY2021Q3 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
140000 usd
CY2022Q3 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
4041 usd
CY2022Q3 us-gaap Defined Benefit Plan Other Costs
DefinedBenefitPlanOtherCosts
544545 usd
CY2022Q3 us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
57971 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
36723 usd
CY2021Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-32160 usd
CY2022Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
101657 usd
CY2021Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
103907 usd
CY2022Q3 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-31052 usd
CY2021Q3 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
965 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
200294 usd
CY2021Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-106007 usd
CY2022Q3 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
9000 usd
CY2021Q3 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-6000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-414610 usd
CY2021Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-878394 usd
CY2021Q3 ngtf Proceeds From The Sale Of Stock
ProceedsFromTheSaleOfStock
-308200 usd
CY2022Q3 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
644000 usd
CY2022Q3 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
289855 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
354145 usd
CY2021Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
308200 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-60465 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-570194 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
280877 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1041899 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
220412 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
471705 usd
CY2022Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
28180 usd
CY2022Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4050 usd
CY2021Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3865 usd
CY2022Q3 ngtf Deemed Dividend Associated With Warrants Dilutive Adjustment
DeemedDividendAssociatedWithWarrantsDilutiveAdjustment
345462 usd
CY2021Q3 ngtf Deemed Dividend Associated With Warrants Dilutive Adjustment
DeemedDividendAssociatedWithWarrantsDilutiveAdjustment
289935 usd
CY2022Q3 us-gaap Nature Of Operations
NatureOfOperations
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. Description of Business</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nightfood Holdings, Inc. (“we”, “us”, “the Company” or “Nightfood”) is a Nevada corporation organized on October 16, 2013 to acquire all of the issued and outstanding shares of Nightfood, Inc., a New York corporation from its sole shareholder, Sean Folkson. All of our operations are conducted through its subsidiary Nightfood, Inc. We are also the sole shareholder of MJ Munchies, Inc., which owns certain intellectual property but does not have any operations as of the period covered by these financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our corporate address is 520 White Plains Road – Suite 500, Tarrytown, New York 10591 and our telephone number is 888-888-6444. We maintain a web site at www.nightfood.com, along with many additional web properties. Any information that may appear on our web site should not be deemed to be a part of this report. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s fiscal year end is June 30.</span></p>
CY2022Q3 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of Estimates</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Estimates are used in the determination of depreciation and amortization, the valuation for non-cash issuances of common stock, and the website, income taxes and contingencies, valuing convertible preferred stock for a “beneficial conversion feature” (“BCF”) and warrants among others.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3 ngtf Federal Depository Insurance Coverage
FederalDepositoryInsuranceCoverage
250000 usd
CY2022Q3 us-gaap Advertising Expense
AdvertisingExpense
37166 usd
CY2021Q3 us-gaap Advertising Expense
AdvertisingExpense
305016 usd
CY2022Q3 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Concentration of Credit Risk</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash deposits at financial institutions. At various times during the year, the Company may exceed the federally insured limits. To mitigate this risk, the Company places its cash deposits only with high credit quality institutions. Management believes the risk of loss is minimal. At September 30, 2022 and June 30, 2022, the Company did not have any uninsured cash deposits.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2022Q3 ngtf Description Of Beneficial Conversion Feature
DescriptionOfBeneficialConversionFeature
Each share of B Preferred is convertible at the option of the holder thereof into (i) 5,000 shares of the Registrant’s common stock (one share for each $0.20 of liquidation preference) (the “Conversion Shares”) and (ii) 5,000 common stock purchase warrants, expiring April 16, 2026 (the “Warrants”). The Warrants carried an initial exercise price of $0.30 per share. Subsequent financing events resulted in adjustments to the exercise price of all warrants created from conversion of B Preferred from $0.30 per share to approximately $0.2725 per share through September 30, 2022.
CY2022Q3 ngtf Customer Concentration Description
CustomerConcentrationDescription
the Company had five customers each accounting for sales exceeding 10% of the gross sales. During the three months ended September 30, 2021, the Company had five customers, each accounting for sales exceeding 10% of the gross sales.
CY2022Q2 ngtf Description Of Receivables Concentration
DescriptionOfReceivablesConcentration
As of June 30, 2022, the Company had receivables due from six customers, one of who accounted for over 59% of the outstanding balance. One of the remaining five accounted for 13.5% of the outstanding balance and one accounted for 11% of the outstanding balance.
CY2022Q3 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Reclassification</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; font-size: 10pt"> </td> <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">●</span></td> <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">The Company may make certain reclassifications to prior period amounts to conform with the current year’s presentation.  Such reclassifications would not have a material effect on its consolidated statement of financial position, results of operations or cash flows.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2022Q3 ngtf Net Loss
NetLoss
1201110 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-414610 usd
CY2022Q3 ngtf Accumulated Deficit
AccumulatedDeficit
29648030 usd
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
158261 usd
CY2022Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
165470 usd
CY2022Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
24324 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
156253 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
82625 usd
CY2022Q3 us-gaap Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
92882 usd
CY2022Q2 us-gaap Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
83436 usd
CY2022Q3 ngtf Inventory Allowance For Unsaleable Invent
InventoryAllowanceForUnsaleableInvent
1468 usd
CY2022Q3 us-gaap Inventory Gross
InventoryGross
433188 usd
CY2022Q2 us-gaap Inventory Gross
InventoryGross
331531 usd
CY2022Q3 us-gaap Disposal Group Including Discontinued Operation Prepaid And Other Assets Current
DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent
106745 usd
CY2022Q2 us-gaap Disposal Group Including Discontinued Operation Prepaid And Other Assets Current
DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent
134797 usd
CY2022Q3 us-gaap Other Restricted Assets Current
OtherRestrictedAssetsCurrent
106745 usd
CY2022Q2 us-gaap Other Restricted Assets Current
OtherRestrictedAssetsCurrent
134797 usd
CY2022Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
9000 usd
CY2022Q2 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
3000 usd
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9000 usd
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3000 usd
CY2021Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.08 pure
CY2021Q4 us-gaap Derivative Swap Type Fixed Price
DerivativeSwapTypeFixedPrice
0.25
CY2021Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.2
CY2022Q3 us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
878260 usd
CY2022Q3 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
170210 usd
CY2022Q3 ngtf Sharebased Goods And Nonemployee Services Transaction Valuation Method Risk Free Interest Rate
SharebasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate
0.0125 pure
CY2022Q3 ngtf Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumption Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionExpectedTerm1
P5Y
CY2022Q3 us-gaap Long Duration Contracts Assumptions By Product And Guarantee Volatility Rate
LongDurationContractsAssumptionsByProductAndGuaranteeVolatilityRate
1.4253 pure
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022Q3 us-gaap Preferred Units Offering Costs
PreferredUnitsOfferingCosts
1000000 usd
CY2022Q3 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
100000 usd
CY2022Q3 us-gaap Legal Fees
LegalFees
15192 usd
CY2022Q3 ngtf Description Of Securities Purchase Agreement
DescriptionOfSecuritiesPurchaseAgreement
On September 23, 2022, the Company entered into a Securities Purchase Agreement and issued and sold to an institutional investor, a Promissory Note (the “Promissory Note”) in the principal sum of $700,000.00, which amount is the $644,000 actual amount of the purchase price plus an original issue discount in the amount of $56,000. In connection with the issuance of the Promissory Note, the Company issued to the investor warrants to purchase 2,800,000 shares of common stock at an exercise price of $0.225, as well as returnable warrants (the “Returnable Warrants”), which may only be exercised in the event that the Company were to default on certain debt obligations, to purchase 7,000,000 shares of common stock at an exercise price of $0.30, in each case subject to adjustment. The Promissory Note may be converted into Company common stock in the event of an event of default under the Promissory Note by the Company. 
CY2022Q3 ngtf Returnable Warrants Term
ReturnableWarrantsTerm
P5Y
CY2022Q3 ngtf Exercise Price Per Share
ExercisePricePerShare
0.3
CY2022Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.1
CY2022Q3 us-gaap Debt Instrument Collateral Fee
DebtInstrumentCollateralFee
1750 usd
CY2022Q3 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
750 usd
CY2022Q3 ngtf Warrants
warrants
5000 shares
CY2022Q3 ngtf Transaction Amount
TransactionAmount
4431387 usd
CY2022Q3 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
604800 usd
CY2022Q3 ngtf Outstanding Share In Percentage
OutstandingShareInPercentage
0.50 pure
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
95964484 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
91814484 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 ngtf Loss On Fair Value
LossOnFairValue
100000 usd
CY2022Q3 ngtf Common Stock Services
commonStockServices
20010 usd
CY2021Q3 ngtf Loss On Fair Value
LossOnFairValue
518519 usd
CY2021Q3 ngtf Common Stock Services
commonStockServices
140000 usd
CY2022Q3 us-gaap Convertible Preferred Stock Shares Reserved For Future Issuance
ConvertiblePreferredStockSharesReservedForFutureIssuance
810 shares
CY2022Q2 us-gaap Investment Sold Not Yet Purchased Balance Shares
InvestmentSoldNotYetPurchasedBalanceShares
335 shares
CY2021Q2 us-gaap Investment Sold Not Yet Purchased Balance Shares
InvestmentSoldNotYetPurchasedBalanceShares
4665 shares
CY2022 us-gaap Demutualization By Insurance Entity Securities Issued Gross Cash Proceeds
DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds
335000 usd
CY2021 us-gaap Demutualization By Insurance Entity Securities Issued Gross Cash Proceeds
DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds
3150000 usd
CY2022 ngtf Description Of Financing Activities
DescriptionOfFinancingActivities
These proceeds were used for operating capital. The B Preferred meets the criteria for equity classification and is accounted for as equity transactions. Specifically, among other factors, this qualifies as equity because redemption is not invoked at the option of the holder and the B Preferred does not have to be redeemed on a specified date.
CY2021 ngtf Converted Shares
ConvertedShares
1740 shares
CY2022Q3 ngtf Converted Shares
ConvertedShares
810 shares
CY2022Q3 ngtf Common Stock Shares
CommonStockShares
4050000 shares
CY2022Q3 ngtf Convertible Notedescription
ConvertibleNotedescription
The Company has never declared dividends, however as set out below, during the fiscal year ended June 30, 2022 and 2021, upon issuance of a total of 335 and 4,665 shares of B Preferred, respectively, the Company recorded a deemed dividend as a result of beneficial conversion feature associated with the transaction. 
CY2022Q3 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
5000 shares
CY2022Q3 us-gaap Class Of Warrant Or Right Unissued
ClassOfWarrantOrRightUnissued
8700000 shares
CY2022 us-gaap Warrant Exercise Price Increase
WarrantExercisePriceIncrease
0.2919
CY2022Q3 ngtf Warrant Description
WarrantDescription
Certain warrants in the below table include dilution protection for the warrant holders, which could cause the exercise price to be adjusted as a result of a financing event at a valuation below the exercise price in effect at the time. For example, as a result of the December 2021 Offering, which would allow the new noteholders to convert their debt to shares of common stock at an exercise price of $0.20/share, some of the $0.30 warrants outstanding in the table below had their exercise price reduced from $0.30 to $0.2919 which was further adjusted to $0.2752 prior to September 30, 2022 upon the occurrence of a further dilutive event. The result of the warrant exercise price downward adjustment on modification date was treated as a deemed dividend and fully amortized on the transaction date, and the Company recorded $91,375 to additional paid in capital and retained earnings on the Company’s balance sheets. In addition to the reduction in exercise price, there is a corresponding increase to the number of warrants to the holder on a prorated basis. Under certain conditions, such as the successful retirement of a convertible note through repayment, it is possible for the exercise price of these warrants to increase. 
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
0 usd
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
11650 usd
CY2022Q3 ngtf Returnable Warrants Issued
ReturnableWarrantsIssued
18956523 shares
CY2022Q3 ngtf Financing Agreement Date
FinancingAgreementDate
2022-09-23
CY2022Q3 ngtf Returnable Warrants Issued
ReturnableWarrantsIssued
7000000 shares
CY2022Q3 ngtf Financing Agreement Date
FinancingAgreementDate
2022-09-23
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.2188 pure
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0391 pure
CY2022Q3 ngtf Additional Financing Costs In Cumulative Amount
AdditionalFinancingCostsInCumulativeAmount
642140 usd
CY2021Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
2794100 usd
CY2022Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
500000 shares
CY2022Q3 us-gaap Stock Option Exercise Price Increase
StockOptionExercisePriceIncrease
0.15
CY2022Q3 us-gaap Debt Instrument Description
DebtInstrumentDescription
●CEO Sean Folkson has a twelve-month consulting agreement which went into effect on January 1, 2022, which will reward him with bonuses earned of 1,000,000 warrants at a strike price of $0.50 when the Company records its first quarter with revenues over $1,000,000, an additional 3,000,000 warrants with a $0.50 strike price when the Company records its first quarter with revenues over $3,000,000, and an additional 3,000,000 warrants with a $1 strike price when the Company records its first quarter with revenues over $5,000,000. Mr. Folkson will also be awarded warrants with a strike price of $0.50 should the Company exceed $500,000 in non-traditional retail channel revenue during the term of the agreement, and should the Company enter into a product development or distribution partnership with a multi-national food & beverage conglomerate during the term of the Agreement. As of September 30, 2022, those conditions were not met and therefore nothing was accrued related to this arrangement.
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Fair Value Disclosure
AccountsPayableAndAccruedLiabilitiesFairValueDisclosure
9000 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Fair Value Disclosure
AccountsPayableAndAccruedLiabilitiesFairValueDisclosure
3000 usd
CY2022Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
400000 shares
CY2022Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.3
CY2022Q4 ngtf Cost Of Per Warrant
CostOfPerWarrant
0.15
CY2022Q4 ngtf Warrants Additional Shares
WarrantsAdditionalShares
80000 shares
CY2022Q4 ngtf Strike Price
StrikePrice
0.2
CY2022Q4 ngtf Aggregate Term
AggregateTerm
P3Y
CY2017Q4 ngtf Consulting Fee
ConsultingFee
12000 usd
us-gaap Stock Issued During Period Shares Purchase Of Assets
StockIssuedDuringPeriodSharesPurchaseOfAssets
400000 shares
CY2019Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.3
CY2019Q4 us-gaap Product Liability Accrual Component Amount
ProductLiabilityAccrualComponentAmount
120000 usd
CY2021Q2 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
9 usd
CY2021Q3 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
0 usd
CY2021Q3 us-gaap Sponsor Fees
SponsorFees
6000 usd
CY2022Q3 us-gaap Related Party Transaction Description Of Transaction
RelatedPartyTransactionDescriptionOfTransaction
Achieving those milestones would earn Mr. Folkson warrants with a $0.50 and $1.00 strike price which would need to be exercised within 90 days of the respective quarterly or annual filing.
CY2022Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
usd
CY2021Q3 ngtf Deemed Dividends Associated
DeemedDividendsAssociated
usd
CY2021Q3 ngtf Warrants Issued For Services
WarrantsIssuedForServices
usd
CY2021Q3 ngtf Warrant Issued For Financing Cost
WarrantIssuedForFinancingCost
usd
CY2021Q3 us-gaap Defined Benefit Plan Other Costs
DefinedBenefitPlanOtherCosts
usd
CY2021Q3 us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
usd
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2021Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2021Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2022Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
usd
CY2022 ngtf Inventory Allowance For Unsaleable Invent
InventoryAllowanceForUnsaleableInvent
usd
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
usd
CY2021Q3 us-gaap Other Assets
OtherAssets
usd
CY2022Q3 dei Amendment Flag
AmendmentFlag
false
CY2022Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2022Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001593001

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001213900-22-074226-index-headers.html Edgar Link pending
0001213900-22-074226-index.html Edgar Link pending
0001213900-22-074226.txt Edgar Link pending
0001213900-22-074226-xbrl.zip Edgar Link pending
f10q0922ex31-1_nightfood.htm Edgar Link pending
f10q0922ex32-1_nightfood.htm Edgar Link pending
f10q0922_nightfood.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
ngtf-20220930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
ngtf-20220930_cal.xml Edgar Link unprocessable
ngtf-20220930_def.xml Edgar Link unprocessable
ngtf-20220930_lab.xml Edgar Link unprocessable
ngtf-20220930_pre.xml Edgar Link unprocessable
f10q0922_nightfood_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending